Adimune™ is a pre-clinical stage company on a mission: to restore immune tolerance and deliver long-lasting treatment results for chronic diseases. With a robust pipeline of medications designed to help individuals facing severe conditions worldwide, our aim is straightforward but impactful – to discover, develop, manufacture, and bring game-changing medicines for various diseases to those in need.
Pearsanta™ is the company to deliver on “Health by the Numbers” to providers and patients through personalized, data-driven diagnostic and monitoring solutions with increased specificity and meaningful insights for optimal health and wellness. As a medical diagnostic and innovation company, Pearsanta addresses biosample collection, processing, and the delivery of actionable information.
Adivir™ is dedicated to developing and delivering innovative medicines, diagnostics, and vaccines that address public health threats and improve population health. They are actively developing a diverse pipeline of commercial, clinical, and pre-clinical candidates to tackle significant unmet patient needs, focusing on public health threats, emerging or neglected infectious diseases, and immunotherapies.
Supported by clinical researchers, chemists, computer science and biostatisticians teams, the Aditxt platforms will unlock next-level technologies and therapies. These innovations will fuel the frontline work in the fight against diseases.
We invite you to join our community of scientists, healthcare professionals, and individuals who share our passion for advancing innovations. Together, we can drive these innovation and meaningfully impact global health.
Mountain View, CA
Discovery and product development
CLIA Accredited 24/7 laboratory operations*
Capital markets, investor and media relations, and business development